RAD1 and mantle cell lymphoma: GSK3326595 treatment led to an increase in the 2 N population in the most sensitive MCL cell lines, Z-138 and JVM-2 (gIC50  < 100 nM) while having no effect on cell cycle distribution in the less sensitive MCL cell lines, JEKO-1, MINO, and REC-1 (gIC50 > 100 nM).